Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 50 of 129

TitleReference numberPublishedLast updated
24/7 EEG SubQ for epilepsyMIB277
3C Patch for treating diabetic foot ulcersMTG66
Acute heart failure: diagnosis and managementCG187
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomasMIB294
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adultsES40
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infectionsES39
Atidarsagene autotemcel for treating metachromatic leukodystrophyHST18
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Bladder EpiCheck for detecting bladder cancer recurrenceMIB293
Brain tumours (primary) and brain metastases in over 16sQS203
Cabotegravir with rilpivirine for treating HIV-1TA757
Cenobamate for treating focal onset seizures in epilepsyTA753
CerebAir for continuous EEG monitoring in intensive careMIB279
Chronic kidney disease: assessment and managementNG203
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infectionsMTG62
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemiaMIB278
Colorectal cancerNG151
Colorectal cancerQS20
Coronary sinus narrowing device implantation for refractory anginaIPG712
d-Nav insulin management app for type 2 diabetesMIB285
Dapagliflozin for treating chronic kidney diseaseTA775
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)TA771
Diabetes in children and young peopleQS125
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyTA779
Dupilumab for treating severe asthma with type 2 inflammationTA751
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodulesDG46
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Empagliflozin for treating chronic heart failure with reduced ejection fractionTA773
Endo-SPONGE for treating low rectal anastomotic leakMTG63
Endoanchoring systems in endovascular aortic aneurysm repairIPG725
Endobronchial nerve ablation for chronic obstructive pulmonary diseaseIPG714
Endoscopic balloon dilation for subglottic or tracheal stenosisIPG719
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomachIPG717
Epilepsies in children, young people and adultsNG217
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisTA756
Fetal alcohol spectrum disorderQS204
Fever in under 5s: assessment and initial managementNG143
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)DG47
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndromeMIB281
Fremanezumab for preventing migraineTA764
Givosiran for treating acute hepatic porphyriaHST16
Glaucoma: diagnosis and managementNG81
Granulox for managing chronic non-healing woundsMIB296
Headaches in over 12s: diagnosis and managementCG150
Heart valve disease presenting in adults: investigation and managementNG208
icobrain ms for active relapsing–remitting multiple sclerosisMIB291
Inducing labourNG207

Results per page

  1. 10
  2. 25
  3. 50
  4. All